Warfarin holds promise in reducing risk of stroke

by Medindia Content Team on  June 10, 2006 at 2:19 PM Drug News
RSS Email Print This Page Comment
Warfarin holds promise in reducing risk of stroke
Researchers are very optimistic about Warfarin, an anti-clotting drug, which holds promise in reducing stroke risk in patients suffering an abnormal heart rhythm, the side effects notwithstanding .

Warfarin scores over the present treatment of Plavix plus aspirin for patients suffering atrail fibrillation in preventing strokes.

In the words of Dr Stuart Connolly, of McMaster University in Hamilton,' Oral anticoagulants such as warfarin remain the treatment of choice for preventing stroke in patients with atrial fibrillation.'

Couadin, the brand name of Warfarin, though connected to an enhanced risk of bleeding, is still capable of reducing stroke by two-thirds.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Diet Lifestyle and Heart Disease Mitral Valve Stenosis And Mitral Valve Replacement Congenital Heart Disease Stress and the Gender Divide Stroke Facts Stroke Hyperventilation Anticoagulants Deep Vein Thrombosis Pulmonary Embolism 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive